Enalare Therapeutics Invited to Present at Upcoming Biotech Conferences
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening critical care conditions, announced today that it has been invited to present at both the H.C. Wainright Bioconnect Conference and the Biotech Showcase 2022 Conference. Herm Cukier, President and CEO of Enalare Therapeutics, will provide an update on the … Read more